unknown
Stage
1
Investors
About
ExVivo develops a next generation medical diagnostic tool for allergy testing using microfluidics technology to make testing safe, simple, and non-invasive.
Explore ExVivo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.